Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avas Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of high-quality prescription products for the dermatology and podiatry markets. The company provides a range of therapeutic solutions designed to treat skin and nail conditions, including hyperkeratotic conditions and fungal infections. Avas Pharmaceuticals emphasizes cost-effective treatments and maintains a portfolio of branded generic products that cater to specific patient needs in skin care. Their business model centers on identifying niche therapeutic areas where they can provide value through specialized formulations and reliable supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avas.